rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-8-1
|
pubmed:abstractText |
The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0002-9149
|
pubmed:author |
pubmed-author:AokiJiroJ,
pubmed-author:McFaddenEugène PEP,
pubmed-author:OngAndrew T LAT,
pubmed-author:RegarEvelynE,
pubmed-author:Rodriguez-GranilloGastón AGA,
pubmed-author:SerruysPatrick WPW,
pubmed-author:SianosGeorgiosG,
pubmed-author:TsuchidaKeiichiK,
pubmed-author:ValgimigliMarcoM,
pubmed-author:de FeyterPim JPJ,
pubmed-author:de JaegerePeter P TPP,
pubmed-author:van DomburgRon TRT,
pubmed-author:van MieghemCarlos A GCA,
pubmed-author:van der GiessenWillem JWJ
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
395-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16054466-Aged,
pubmed-meshheading:16054466-Coronary Angiography,
pubmed-meshheading:16054466-Coronary Restenosis,
pubmed-meshheading:16054466-Female,
pubmed-meshheading:16054466-Follow-Up Studies,
pubmed-meshheading:16054466-Graft Occlusion, Vascular,
pubmed-meshheading:16054466-Humans,
pubmed-meshheading:16054466-Male,
pubmed-meshheading:16054466-Paclitaxel,
pubmed-meshheading:16054466-Prospective Studies,
pubmed-meshheading:16054466-Saphenous Vein,
pubmed-meshheading:16054466-Stents,
pubmed-meshheading:16054466-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents.
|
pubmed:affiliation |
Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|